Circulating Cell-Free DNA as a potential Diagnostic Tool in Pancreatic Cancer: A Comparative Analysis

Key Points

• The aim is to explore the use of circulating free DNA as a diagnostic tool in pancreatic cancer.
• Conducted comparative analysis of circulating free DNA levels
• Evaluated genetic alterations in patients with pancreatic adenocarcinoma
• Assessed correlations with tumor differentiation and disease progression
• Circulating free DNA levels correlated with poorer tumor differentiation
• Identified potential for cfDNA in evaluating treatment efficacy
• Insufficient data highlights the need for further research in this area